FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Toshida Indonesia CEO Arrested in Nickel Mining Bribery Probe

By

Indonesian prosecutors arrested Toshida Indonesia's CEO Laode Sinarwan Oda over bribery allegations in connection with a nickel mining governance corruption case in Southeast Sulawesi, The Jakarta Post reported Tuesday.

Laode's arrest came over allegations of bribes to Indonesian Ombudsman chairman Hery Susanto, who was also reportedly arrested in April.

Laode failed to appear when he was summoned, which led to the arrest, The Jakarta Post reported, citing Attorney General's Office spokesperson Anang Supriatna.

Prosecutors allege the firm attempted to challenge or alter a policy governing the payment of fees to be made to the Forestry Ministry for mining land concessions through the Ombudsman, according to the report.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Singapore Exchange Reports 6% Rise in Securities Market Turnover in April

Singapore Exchange (SGX:S68) reported a 6% year-over-year rise in securities market turnover to SG$43.2 billion in April, according to an after-market filing with the Singapore Exchange on Wednesday.Securities daily average value, or SDAV, also jumped 6% year over year to SG$2.1 billion, while derivatives traded volume edged up 1% on year to 30.2 million contracts, with derivatives daily average volume increasing slightly to about 1.5 million contracts.The steady trading volumes were driven by strong participation in small and mid-cap stocks, with SDAV of those stocks rising 8% month over month.Meanwhile, assets under management across exchange-traded funds or ETFs, crossed SG$20 billion in April, representing a 45% year-over-year surge.

$SGX:S68
Asia

Henlius Biotech Gets Nod for Tumor Drug Trial in Australia

Shanghai Henlius Biotech (HKG:2696) obtained approval for a phase 1 clinical trial of HLX48 for injection from Australia's relevant regulatory authorities, according to a Wednesday Hong Kong bourse filing.The drug will be tested for the treatment of advanced/metastatic solid tumors.

$HKG:2696
Asia

Kabra Extrusiontechnik Appoints Interim CFO

Kabra Extrusiontechnik (NSE:KABRAEXTRU, BOM:524109) has appointed Uttam Singh, currently the deputy general manager-accounts and finance, as the interim chief financial officer, according to a Wednesday filing to the Indian stock exchanges.His appointment is effective from Wednesday till a new CFO is appointed by the board.

$BOM:524109$NSE:KABRAEXTRU